Precision BioLogic’s principal focus is in the field of hemostasis for which we developed CRYOcheck™, a line of specialized high-quality frozen plasmas, reagents and integrated test kits used in the assessment of coagulation disorders. From our facility in Dartmouth, we currently serve more than 1,000 labs throughout North America with direct overnight delivery, and work with distribution partners to sell to customers overseas.
In conjunction with our laboratory, biotech and pharmaceutical partners, we’re also developing new products to improve patient outcomes by addressing current and future challenges in the diagnosis and therapeutic monitoring of disease.
News Release: Precision BioLogic Launches Product to Improve Inhibitor Testing for People with Hemophilia A
HALIFAX, February 11, 2019—Precision BioLogic Inc., a leading developer of hemostasis diagnostic products, is pleased to announce the availability of its new CRYOcheck Factor VIII Inhibitor Kit in Canada, the European Union, Australia, and New Zealand following market...
Working to Improve Hemophilia A Testing: Precision BioLogic presents new data at the 64th Annual SSC meeting
Precision BioLogic Presents New Approach to Standardize and Improve Inhibitor Testing for People with Hemophilia A